Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. Issue 3 (6th January 2017)
- Record Type:
- Journal Article
- Title:
- Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. Issue 3 (6th January 2017)
- Main Title:
- Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine
- Authors:
- Kaino, Kenta
Kumagai, Ryo
Furukawa, Shoko
Isono, Momoko
Muramatsu, Aiko
Fujii, Masanao
Muta, Yumiko
Asada, Tomoyuki
Fujihara, Kazuya
Yagyu, Hiroaki - Abstract:
- Abstract : The first case of MERS caused by olanzapine‐induced HHS and NMS is reported. Diffusion‐weighted image of brain MRI showed high intensity lesions in the SCC. Abstract: A 27‐year‐old woman with panic disorder taking 20 mg olanzapine daily for 4 months was admitted to Mito Kyodo General Hospital, Mito, Ibaraki, Japan, because of disturbed consciousness with fever, hyperglycemia, hyperosmolarity and elevated creatine phosphokinase. She was diagnosed with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome. Brain magnetic resonance imaging showed transiently restricted diffusion in the splenium of the corpus callosum, with a high signal intensity on diffusion‐weighted imaging. The neurological abnormalities disappeared along with improvement of metabolic derangements, and the follow‐up magnetic resonance imaging carried out on the 26th day of admission showed complete resolution of the lesions in the splenium of the corpus callosum. These clinical and radiological features are highly suggestive of clinically mild encephalitis/encephalopathy with a reversible splenial lesion. The first case of mild encephalitis/encephalopathy with a reversible splenial lesion caused by olanzapine‐induced hyperosmolar hyperglycemic state and neuroleptic malignant syndrome is reported.
- Is Part Of:
- Journal of diabetes investigation. Volume 8:Issue 3(2017)
- Journal:
- Journal of diabetes investigation
- Issue:
- Volume 8:Issue 3(2017)
- Issue Display:
- Volume 8, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 8
- Issue:
- 3
- Issue Sort Value:
- 2017-0008-0003-0000
- Page Start:
- 392
- Page End:
- 394
- Publication Date:
- 2017-01-06
- Subjects:
- Diabetes mellitus -- Neuroleptic malignant syndrome -- Olanzapine
Diabetes -- Periodicals
Diabetes -- Research -- Periodicals
Diabetes Mellitus -- Periodicals
616.462005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2040-1124 ↗
http://www3.interscience.wiley.com/journal/122630068/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jdi.12597 ↗
- Languages:
- English
- ISSNs:
- 2040-1116
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 189.xml